Molecular cloning and DNA sequence analysis of genes encoding cytotoxic T lymphocyte-defined HLA-A3 subtypes: the E1 subtype
- PMID: 2993417
Molecular cloning and DNA sequence analysis of genes encoding cytotoxic T lymphocyte-defined HLA-A3 subtypes: the E1 subtype
Abstract
Influenza-specific cytotoxic T cells restricted by HLA-A3 and allogeneic CTL specific for HLA-A3 recognize differences between serologically indistinguishable HLA-A3 antigens. Previous biochemical studies have indicated that such differential recognition can be explained by alterations in the primary structure of class I heavy chains. Characterization of these sequence differences may therefore identify portions of the class I molecule that form determinants recognized by CTL. In this study, we describe the cloning and sequencing of an HLA-A3 subtype from donor E1 (E1-A3). Cloning of the gene encoding E1-A3 was simplified by determining that a 15.5-kb BamHI fragment contains the complete gene and is characteristic of HLA-A3 and only one other class I gene (HLA-A11). Comparison of the E1-A3 sequence to that of a previously sequenced HLA-A3 gene for exons encoding extracellular class I domains revealed three nucleotide differences. All of these differences were located within a discrete region of exon 3 (encoding the alpha 2 domain) and result in a change of two amino acids, at positions 152 (Glu----Val) and 156 (Leu----Gln). This finding suggests that these amino acids are crucial for the information of a determinant recognized by CTL. Furthermore, the altered nucleotide sequence of E1-A3 is identical to the sequence of the HLA-Aw24 gene for codons 128 to 161. These observations of multiple clustered changes in the E1-A3 subtype (relative to the prototype sequence) and identity of the altered sequence with the sequence of another class I gene support the concept that gene conversion is a primary mechanism for the generation of class I polymorphism.
Similar articles
-
Comparative structural analysis of HLA-A3 antigens distinguishable by cytotoxic T lymphocytes: variant E1.J Immunol. 1985 Jan;134(1):410-6. J Immunol. 1985. PMID: 3871112
-
Analysis of the molecular basis of HLA-A3 recognition by cytotoxic T cells using defined mutants of the HLA-A3 molecule.J Immunol. 1988 Aug 15;141(4):1108-13. J Immunol. 1988. PMID: 2456340
-
Cloning and complete sequence of an HLA-A2 gene: analysis of two HLA-A alleles at the nucleotide level.J Immunol. 1985 Apr;134(4):2727-33. J Immunol. 1985. PMID: 2982951
-
Immunodominance across HLA polymorphism: implications for cancer immunotherapy.J Immunother. 1998 Jan;21(1):1-16. J Immunother. 1998. PMID: 9456431 Review.
-
HLA class I genes: from structure to expression, serology and function.Immunol Rev. 1985 Jul;84:73-92. doi: 10.1111/j.1600-065x.1985.tb01126.x. Immunol Rev. 1985. PMID: 3899912 Review.
Cited by
-
The X chromosome shows less genetic variation at restriction sites than the autosomes.Am J Hum Genet. 1986 Oct;39(4):438-51. Am J Hum Genet. 1986. PMID: 2876629 Free PMC article.
-
Polymorphism of human minor histocompatibility antigens: T cell recognition of human minor histocompatibility peptides presented by HLA-B35 subtype molecules.J Exp Med. 1995 Jun 1;181(6):2037-48. doi: 10.1084/jem.181.6.2037. J Exp Med. 1995. PMID: 7759996 Free PMC article.
-
DNA sequence of HLA-A11: remarkable homology with HLA-A3 allows identification of residues involved in epitopes recognized by antibodies and T cells.Immunogenetics. 1987;25(4):241-50. doi: 10.1007/BF00404694. Immunogenetics. 1987. PMID: 2437024
-
Allelic variations clustered in the antigen binding sites of HLA-Bw62 molecules.Immunogenetics. 1993;37(2):108-13. doi: 10.1007/BF00216833. Immunogenetics. 1993. PMID: 8423049
-
Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate.J Clin Invest. 1993 May;91(5):2288-95. doi: 10.1172/JCI116457. J Clin Invest. 1993. PMID: 8486788 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials